Amlodipine and valsartan as components of a rational and effective fixed-dose combination

References

• HeJWheltonPKEpidemiology and prevention of hypertensionMed Clin North Am199781107710979308599
   PubMed Web of Science ®Google Scholar
• EzzatiMLopezADRodgersAVander HoornSMurrayCJSelected major risk factors and global and regional burden of diseaseLancet20023601347136012423980
   PubMed Web of Science ®Google Scholar
• TurnbullFNealBAlgertCEffects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trialsArch Int Med20051651410141915983291
   PubMed Web of Science ®Google Scholar
• StaessenJALiYThijsLWangJGBlood pressure reduction and cardiovascular prevention: an update including the 2003–2004 secondary prevention trialsHypertens Res20052838540716156503
   PubMed Web of Science ®Google Scholar
• WilliamsBRecent hypertension trials: implications and controversiesJ Am Coll Cardiol20054581382715766813
   PubMed Web of Science ®Google Scholar
• ManciaGDe BackerGDominiczakA2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)J Hypertens2007251105118717563527
   PubMed Web of Science ®Google Scholar
• DickersonCJEHingoraniADAshbyMJPalmerCRBrownMJOptimisation of antihypertensive treatment by crossover rotation of four major classesLancet19993532008201310376615
   PubMed Web of Science ®Google Scholar
• LawMRWaldNJMorrisJKJordanREValue of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trialsBMJ20033261427143112829555
   PubMed Web of Science ®Google Scholar
• DeziiCMA retrospective study of persistence with single-pill combination therapy vs concurrent two-pill therapy in patients with hypertensionManag Care20009Suppl2611729417
   PubMedGoogle Scholar
• PloskerGLRobinsonDMAmlodipine/Valsartan: fixed-dose combination in hypertensionDrugs20086837338118257612
   PubMed Web of Science ®Google Scholar
• AbernethyDRSchwartzJBCalcium-antagonist drugsN Engl J Med19993411447145710547409
   PubMed Web of Science ®Google Scholar
• LuscherTFCosentinoFThe classification of calcium antagonists and their selection in the treatment of hypertensionDrugs1998555095179561341
   PubMed Web of Science ®Google Scholar
• MeredithPAElliottHLClinical pharmacokinetics of amlodipineClin Pharmacokinet19922222311532771
   PubMed Web of Science ®Google Scholar
• GrossmanEMesserliFHEffect of calcium antagonists on plasma norepinephrine levels, heart rate, and blood pressureAm J Cardiol199780145314589399721
   PubMed Web of Science ®Google Scholar
• BeeversDGSleightPShort acting dihydropyridine (vasodilating) calcium channel blockers for hypertension: is there a risk?BMJ1996312114311458620133
   PubMedGoogle Scholar
• BinggeliCCortiRSudanoILuscherTFNollGNollGEffects of chronic calcium channel blockade on sympathetic nerve activity in hypertensionHypertension20023989289611967245
   PubMed Web of Science ®Google Scholar
• MarkhamAGoaKLValsartan. A review of its pharmacology and therapeutic use in essential hypertensionDrugs1997542993119257084
   PubMed Web of Science ®Google Scholar
• ThurmannPAValsartan: a novel angiotensin type 1 receptor antagonistExp Opin Pharmacother20001337350
   PubMedGoogle Scholar
• NiarchosAPPickeringTGMorgantiALaraghJHPlasma catecholamines and cardiovascular responses during converting enzyme inhibition in normotensive and hypertensive manClin Exp Hypertens19824761789
   Google Scholar
• SeljeflotIMoanAKjeldsenSSandvikEArnesenHEffect of angiotensin II receptor blockade on fibrinolysis during acute hyperinsulinemia in patients with essential hypertensionHypertension199627129913048641739
   PubMed Web of Science ®Google Scholar
• JuliusSKjeldsenSEWeberMOutcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trialLancet20043632022203115207952
   PubMed Web of Science ®Google Scholar
• MesserliFHVasodilatory edema: a common side effect of antihypertensive therapyCurr Cardiol Rep2002447948212379167
   PubMedGoogle Scholar
• SeverPNew hypertension guidelines from the National Institute for Health and Clinical Excellence and the British Hypertension SocietyJ Renin Angiotensin Aldosterone Syst20067616317083059
   PubMed Web of Science ®Google Scholar
• TextorSCRenovascular hypertension in 2007: where are we now?Curr Cardiol Rep2007945346117999870
   PubMedGoogle Scholar
• GennariCNamiRPaveseGGragnaniSBianchiniCBuracchiPCalcium-channel blockade (nitrendipine) in combination with ACE inhibition (captopril) in the treatment of mild to moderate hypertensionCardiovasc Drugs Ther19893Suppl 13193252487803
   PubMedGoogle Scholar
• LuftFCAronoffGRSloanRSFinebergNSWeinbergerMHCalcium channel blockade with nitrendipine. Effects on sodium homeostasis, the renin-angiotensin system, and the sympathetic nervous system in humansHypertension198574384423158605
   PubMed Web of Science ®Google Scholar
• PhilippTSmithTRGlazerRTwo multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertensionClin Ther20072956358017617280
   PubMed Web of Science ®Google Scholar
• FogariRZoppiADerosaGEffect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patientsJ Hum Hypertens20072122022417215848
   PubMed Web of Science ®Google Scholar
• SmithTRPhilippTVaisseBAmlodipine and valsartan combined and as monotherapy in stage 2, elderly, and black hypertensive patients: subgroup analyses of 2 randomized, placebo-controlled studiesJ Clin Hypertens (Greenwhich)20079355364
   PubMedGoogle Scholar
• MatersonBJRedaDJCushmanWCSingle-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive AgentsN Engl J Med19933289149218446138
   PubMed Web of Science ®Google Scholar
• PoldermansDGlazesRKargiannisSTolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertensionClin Ther20072927928917472820
   PubMed Web of Science ®Google Scholar
• ChobanianAVBakrisGLBlackHRSeventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension2003421206125214656957
   PubMed Web of Science ®Google Scholar
• StergiouGSMakrisTPapavasiliouMEfstathiouSManolisAComparison of antihypertensive effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist and a diuretic in patients with hypertension not controlled by angiotensin receptor blocker monotherapyJ Hypertens20052388388915775795
   PubMed Web of Science ®Google Scholar
• JamersonKABakrisGLWunCCRationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertensionAm J Hypertens20041779380115363822
   PubMed Web of Science ®Google Scholar
• JamersonKWeberMABakrisGLBenazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patientsN Engl J Med20083592417242819052124
   PubMed Web of Science ®Google Scholar